Olfactory Disorder Clinical Trial
Official title:
At-Home Olfactory Training With Essential-Oil Based Scents
The purpose of this study is to determine the impact of a twice daily at-home olfactory training program with a twenty scent, essential oil-based smell test in patients with olfactory dysfunction.
This study randomizes participants to receive either a four scent or fourteen scent olfactory retraining protocol. Baseline olfaction will be tested with a currently commercially available smell test as well as an essential oil based smell test. The protocol involves twice daily retraining where the participant inhales the scent and makes a mental note of what they should be smelling. The training period is six months total with a visit at 3 months to re-assess smell function as well as at six months. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02985515 -
Steroid Nasal Irrigation for Flavor Evaluation and Detection Study
|
N/A | |
Recruiting |
NCT06066307 -
Olfactory Performance in Culinary Arts Students
|
Phase 4 | |
Completed |
NCT05445921 -
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
|
Phase 1/Phase 2 | |
Recruiting |
NCT05855369 -
Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss
|
Phase 2/Phase 3 | |
Recruiting |
NCT03574701 -
Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL
|
N/A | |
Enrolling by invitation |
NCT04764981 -
Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)
|
N/A | |
Completed |
NCT03990766 -
Smell Changes & Efficacy of Nasal Theophylline
|
Phase 2 | |
Withdrawn |
NCT05542095 -
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
|
Phase 1 | |
Recruiting |
NCT04791436 -
Oral and Olfactory Complications of Recovered COVID-19 Patients
|
||
Enrolling by invitation |
NCT05038475 -
Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
|
||
Completed |
NCT01332825 -
cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
|
N/A | |
Completed |
NCT04789499 -
Smell in Covid-19 and Efficacy of Nasal Theophylline
|
Phase 2 | |
Active, not recruiting |
NCT04761458 -
Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality
|
N/A | |
Completed |
NCT04406584 -
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
|
N/A | |
Completed |
NCT04700891 -
Correlation of Preoperative Olfactory Identification Function With Frailty and Postoperative Complications and Mortality
|
N/A | |
Recruiting |
NCT04466982 -
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
|
||
Recruiting |
NCT04869436 -
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
|
Phase 4 | |
Recruiting |
NCT05448898 -
The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction
|
N/A | |
Completed |
NCT04235153 -
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
|